Said Suliman, A.; Rehmani, S.; Small, B.; Butcher, K.; Khoder, M.; Kannappan, V.; Wang, W.; Elhissi, A.; Najlah, M.
PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer. Pharmaceuticals 2025, 18, 487.
https://doi.org/10.3390/ph18040487
AMA Style
Said Suliman A, Rehmani S, Small B, Butcher K, Khoder M, Kannappan V, Wang W, Elhissi A, Najlah M.
PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer. Pharmaceuticals. 2025; 18(4):487.
https://doi.org/10.3390/ph18040487
Chicago/Turabian Style
Said Suliman, Ammar, Sahrish Rehmani, Benjamin Small, Kate Butcher, Mouhamad Khoder, Vinodh Kannappan, Weiguang Wang, Abdelbary Elhissi, and Mohammad Najlah.
2025. "PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer" Pharmaceuticals 18, no. 4: 487.
https://doi.org/10.3390/ph18040487
APA Style
Said Suliman, A., Rehmani, S., Small, B., Butcher, K., Khoder, M., Kannappan, V., Wang, W., Elhissi, A., & Najlah, M.
(2025). PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer. Pharmaceuticals, 18(4), 487.
https://doi.org/10.3390/ph18040487
